However, a multicenter phase 3 study indicated that 13 adjuvant treatment with the recombinant MAGE-A3 protein AS15 did not increase disease-free survival in surgically resected NSCLC patients that were MAGE-A3-positive. The gene discussed is MAGEA3; the disease is non-small cell lung carcinoma.